These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 7933704)

  • 21. [Local carbonic anhydrase inhibitors MK-927 and Mk-417. Effect and tolerance].
    Gerling J; Pfeiffer N; Lippa E; Brunner-Ferber F; Grehn F
    Fortschr Ophthalmol; 1990; 87(6):692-5. PubMed ID: 2086420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular and systemic effects of acetazolamide in nephrectomized rabbits.
    Friedman Z; Krupin T; Becker B
    Invest Ophthalmol Vis Sci; 1982 Aug; 23(2):209-13. PubMed ID: 6807936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MK-507 (L-671,152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys.
    Wang RF; Serle JB; Podos SM; Sugrue MF
    Arch Ophthalmol; 1991 Sep; 109(9):1297-9. PubMed ID: 1929960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors.
    Brechue WF; Maren TH
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2581-7. PubMed ID: 8325759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new approach to the study of aqueous humor dynamics by measuring the intensity of Tyndall's effect.
    Oshika T; Mori M; Araie M
    J Fr Ophtalmol; 1990; 13(10):471-80. PubMed ID: 2081836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of bimatoprost on intraocular pressure in prostaglandin FP receptor knockout mice.
    Crowston JG; Lindsey JD; Morris CA; Wheeler L; Medeiros FA; Weinreb RN
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4571-7. PubMed ID: 16303950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute effects of topical forskolin on aqueous humor dynamics in man.
    Seto C; Eguchi S; Araie M; Matsumoto S; Takase M
    Jpn J Ophthalmol; 1986; 30(3):238-44. PubMed ID: 3784136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aqueous humor flow in human eyes treated with dorzolamide and different doses of acetazolamide.
    Larsson LI; Alm A
    Arch Ophthalmol; 1998 Jan; 116(1):19-24. PubMed ID: 9445204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-dependent pharmacokinetics of MK-417, a potent carbonic anhydrase inhibitor, in rabbits following single and multiple doses.
    Lin JH; Chen IW; Ulm EH; Gehret JR; Duggan DE
    Drug Metab Dispos; 1990; 18(6):836-41. PubMed ID: 1981525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical and pharmacological properties of MK-927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical route.
    Maren TH; Bar-Ilan A; Conroy CW; Brechue WF
    Exp Eye Res; 1990 Jan; 50(1):27-36. PubMed ID: 2307193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of topical administration of 1% brinzolamide on intraocular pressure in clinically normal horses.
    Germann SE; Matheis FL; Rampazzo A; Burger D; Roos M; Spiess BM
    Equine Vet J; 2008 Nov; 40(7):662-5. PubMed ID: 18487097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the effectiveness of dorzolamide and acetazolamide in preventing post-operative intraocular pressure rise following phacoemulsification surgery.
    Zohdy GA; Rogers ZA; Lukaris A; Sells M; Roberts-Harry TJ
    J R Coll Surg Edinb; 1998 Oct; 43(5):344-6. PubMed ID: 9803110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of K-115, a rho-kinase inhibitor, on aqueous humor dynamics in rabbits.
    Isobe T; Mizuno K; Kaneko Y; Ohta M; Koide T; Tanabe S
    Curr Eye Res; 2014 Aug; 39(8):813-22. PubMed ID: 24502505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MK-927: a topically active ocular hypotensive carbonic anhydrase inhibitor.
    Sugrue MF; Gautheron P; Grove J; Mallorga P; Viader MP; Schwam H; Baldwin JJ; Christy ME; Ponticello GS
    J Ocul Pharmacol; 1990; 6(1):9-22. PubMed ID: 2362161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of topically applied 2% pilocarpine and 0.25% demecarium bromide on blood-aqueous barrier permeability in dogs.
    Krohne SG
    Am J Vet Res; 1994 Dec; 55(12):1729-33. PubMed ID: 7887518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of topical application of a 2% solution of dorzolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs.
    Cawrse MA; Ward DA; Hendrix DV
    Am J Vet Res; 2001 Jun; 62(6):859-63. PubMed ID: 11400841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacokinetics of dorzolamide.
    Martens-Lobenhoffer J; Banditt P
    Clin Pharmacokinet; 2002; 41(3):197-205. PubMed ID: 11929320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A new topical carbonic anhydrase inhibitor (MK-927). Tolerance comparison with betaxolol in healthy probands].
    Feicht B; Hofmann HM; Lippa E; Brunner-Ferber F; von Denffer H; Merté HJ
    Klin Monbl Augenheilkd; 1990 Sep; 197(3):254-7. PubMed ID: 2255169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of intraocular pressure lowering by topical and systemic carbonic anhydrase inhibitors in the rabbit.
    Fanous MM; Challa P; Maren TH
    J Ocul Pharmacol Ther; 1999 Feb; 15(1):51-7. PubMed ID: 10048347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of MK-927, a topical carbonic anhydrase inhibitor, on IOP in glaucomatous monkeys.
    Wang RF; Serle JB; Podos SM; Surgrue MF
    Curr Eye Res; 1990 Feb; 9(2):163-8. PubMed ID: 2335112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.